Sign in

CIK 0001607678 · Large accelerated filer

Viking Therapeutics, Inc.

Sign in to watch
Ticker
VKTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
461073877
Phone
858-704-4660
Business address
9920 PACIFIC HEIGHTS BLVD, SUITE 500, SAN DIEGO, CA
  1. 8-K Event Regulation FD disclosure
  2. 8-K Event Executive or director change · Shareholder vote results
  3. S-8 POS Other Post-effective Amendment
  4. S-8 POS Other Post-effective Amendment
  5. S-8 POS Other Post-effective Amendment
  6. S-8 POS Other Post-effective Amendment
  7. S-8 POS Other Post-effective Amendment
  8. S-8 POS Other Post-effective Amendment
  9. S-8 POS Other Post-effective Amendment
  10. S-8 POS Other Post-effective Amendment
  11. S-8 POS Other Post-effective Amendment
  12. S-8 POS Other Post-effective Amendment
  13. S-8 POS Other Post-effective Amendment
  14. S-8 Other Securities Offered to Employees in Benefit Plans
  15. 4 Planned sale Chief Financial Officer sold 66,756 shares at an average $74.69 ($4,986,008)
  16. 144 Insider Sale of Securities
  17. 4 Planned sale Chief Operating Officer sold 281,425 shares at an average $78.66 ($22,136,474)
  18. 144 Insider Sale of Securities
  19. 10-Q Report Quarterly Report
  20. 8-K Event Results of operations

Page 8 of 33 · 652 filings